US Stock MarketDetailed Quotes

ANIK Anika Therapeutics

Watchlist
  • 14.700
  • +0.010+0.07%
Trading Apr 30 13:03 ET
210.82MMarket Cap-3.84P/E (TTM)

About Anika Therapeutics Company

Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company's main focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and its products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.

Company Profile

SymbolANIK
Company NameAnika Therapeutics
Listing DateNov 25, 1997
Founded1992
CEODr. Cheryl R. Blanchard, PhD
MarketNASDAQ
Employees288
Fiscal Year Ends12-31
Address32 Wiggins Avenue
CityBedford
ProvinceMassachusetts
CountryUnited States of America
Zip Code01730
Phone1-781-457-9000

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Cheryl R. Blanchard, PhD
  • Director, President and Chief Executive Officer
  • 5.10M
  • Stephen D. Griffin
  • Executive Vice President, Chief Financial Officer and Chief Operating Officer
  • 2.65M
  • Ian James Winward McLeod
  • Vice President, Chief Accounting Officer and Treasurer
  • --
  • David B. Colleran
  • Executive Vice President, General Counsel and Secretary
  • 1.67M
  • John B. Henneman, III
  • Chairman of the Board
  • 252.64K
  • Susan L.N. Vogt
  • Independent Director
  • 223.99K
  • Sheryl L. Conley
  • Independent Director
  • 221.63K
  • William R. Jellison
  • Independent Director
  • 198.37K
  • Stephen O. Richard
  • Independent Director
  • 227.63K
  • Joseph H. Capper
  • Independent Director
  • 196.99K
  • Gary P. Fischetti
  • Independent Director
  • 215.24K
  • Dr. Glenn R. Larsen, PhD
  • Independent Director
  • 212.49K

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More